FDI screening, long-stop dates and risk allocation in Dutch technology transactions
Category: InsightsFDI screening, long-stop dates and risk allocation in Dutch technology transactions
Dutch Vifo screening is not a late-stage regulatory formality. In acquisitions or investments involving Dutch technology targets, it can affect transaction structure, diligence, signing, closing, access to sensitive information and risk allocation between buyer, seller and investor.
This is particularly relevant for transactions involving AI, cybersecurity, semiconductors, quantum, photonics, dual-use technology, biotech, advanced materials, sensor and navigation technology or other sensitive technology. For professional deal teams, the question is not only whether a filing is required. The more important drafting question is how the risk is allocated in the SPA or investment agreement.
This article is part of ViottaLaw’s Dutch M&A Insights and connects to Vifo screening and foreign investments in Dutch acquisitions, Dutch Vifo Act expanded 2027, signing and closing in Dutch M&A, Dutch VC Insights and Private Equity Insights.
When Vifo becomes a transaction condition
Vifo becomes a transaction issue when the Dutch target may fall within the scope of the Dutch investment screening regime and the transaction may result in control, influence or access that is relevant for national security assessment.
In a full acquisition, this is often clear. In minority investments, the analysis may be more subtle. Veto rights, reserved matters, board observer rights, enhanced information rights, class approvals or governance arrangements may matter when the target operates in sensitive technology.
For foreign buyers, VC funds, PE sponsors and international counsel, this means the Vifo analysis should begin at term sheet or LOI stage. Waiting until the SPA is nearly final can create avoidable closing risk.
From scope analysis to condition precedent
The first step is a scope analysis. What technology does the target develop or control? Which customers, data, IP, infrastructure, security functions or public-sector relationships are relevant? What rights will the buyer or investor receive? How is the buyer’s ownership chain structured?
If a filing may be required, the SPA or investment agreement should make closing conditional upon either confirmation that no filing is required or the relevant clearance being obtained.
A generic regulatory approval condition is often too broad. The drafting should identify the relevant Dutch screening regime, the filing responsibility, the information undertakings, the cooperation obligations and the treatment of conditional clearance.
Filing responsibility and information undertakings
A Vifo process requires information from both sides.
The buyer or investor may need to provide information on ownership, UBOs, control, financing, governance, foreign-state links and background. The target may need to provide information on technology, activities, customers, contracts, data, security, governance and strategic relevance.
The transaction documents should therefore include a clear cooperation covenant. Who prepares the filing? Who leads contact with the Dutch Investment Screening Bureau? Who reviews drafts? What information must be provided, by when and subject to what confidentiality protections?
This is particularly important where the target’s technical information is sensitive and should not be broadly shared before clearance.
Long-stop date, efforts standard and termination rights
The long-stop date should reflect the expected screening process. A short long-stop date may create unnecessary deal pressure. A long long-stop date may be unattractive for sellers who have granted exclusivity and lost momentum with alternative bidders.
The efforts standard is equally important. Is the buyer required to use reasonable efforts only? Must it accept mitigation measures? Is there a hell-or-high-water obligation? Can the buyer refuse clearance conditions that restrict governance, technology access, commercial integration or future transferability?
Termination rights should also be specific. Who may terminate if clearance is not obtained? What happens if one party fails to cooperate? Are costs shared? Is there any break fee or reverse break fee? Does the seller have a right to terminate if the review process exceeds an agreed period?
These points should not be left to boilerplate.
Conditional clearance
Vifo clearance may come with conditions. Those conditions may affect governance, technology access, security measures, information flows, business operations or future transfers.
That is why a condition precedent simply referring to “approval” can be insufficient. The SPA or investment agreement should address whether clearance subject to conditions satisfies the condition precedent and, if not, what level of conditions is unacceptable.
This is a key negotiation point. A buyer does not want to be forced to complete a transaction if clearance materially changes the deal. A seller does not want the buyer to use minor conditions as an exit route.
Practical clause checklist
A Dutch Vifo clause should usually cover: scope analysis, filing responsibility, information undertakings, cooperation covenant, confidentiality, standstill, condition precedent, long-stop date, efforts standard, mitigation measures, cost allocation, interim covenants and termination rights.
For cross-border technology transactions, these points should be mapped in a transaction matrix: issue, responsible party, document, deadline and consequence for closing.
Practical conclusion
Vifo screening can directly affect closing certainty in Dutch technology transactions. It is not only a regulatory question; it is a drafting and risk allocation issue.
For foreign buyers, PE and VC investors, sellers and international counsel, the practical rule is simple: analyze Vifo early and translate the outcome into clear SPA or investment agreement mechanics.
FAQ
Can a Dutch SPA be signed before a Vifo filing is made?
Yes, but if filing risk exists, completion should usually be conditional on clearance or on confirmation that no filing is required.
Can the transaction close while the Vifo review is pending?
If a filing is mandatory, the transaction generally cannot be implemented before clearance.
Who bears the risk of conditional clearance?
The SPA or investment agreement should allocate that risk. The drafting should define which conditions are acceptable and which are materially burdensome.
How should the long-stop date be set?
It should reflect the expected screening timetable, transaction complexity, seller exposure and the buyer’s filing obligations.
Can minority investments be relevant under Vifo?
Yes. In sensitive technology companies, significant influence through governance or information rights may be relevant even without full control.
About Dirk de Waard
Dirk de Waard is a Dutch corporate, M&A and venture capital lawyer and partner at Venture Lawyers in Amsterdam. He advises foreign buyers, PE and VC investors, sellers, founders and international counsel on Dutch acquisitions, investments, Vifo screening, SPA drafting, governance and closing mechanics.
ViottaLaw is Dirk’s personal insights platform. Legal services are provided through Venture Lawyers.
Need Dutch Vifo drafting support?
A Dutch technology acquisition or investment may require a clear Vifo condition precedent, long-stop date, cooperation covenant, efforts standard and termination framework.
Dirk de Waard advises international buyers, investors and counsel on Dutch Vifo implementation in transaction documents. Contact Dirk at dirk.dewaard@viottalaw.com to review the Dutch screening and closing mechanics of a proposed transaction.
